Although PD-L2 can also bind to PD-1 as a ligand with significantly higher affinity than PD-L1 [5], the interaction of PD-1 with PD-L1 plays the decisive role in antibody-based anti-tumor immunotherapies [4]. This evidence concerns the gene CD274 and neoplasm.